{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T06:36:25Z","timestamp":1781073385770,"version":"3.54.1"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100002855","name":"Chinese Ministry of Science and Technology","doi-asserted-by":"publisher","award":["2007AA022402"],"award-info":[{"award-number":["2007AA022402"]}],"id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biologicals"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.biologicals.2018.06.003","type":"journal-article","created":{"date-parts":[[2018,6,30]],"date-time":"2018-06-30T18:04:19Z","timestamp":1530381859000},"page":"59-62","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Development of a relative potency test using ELISA for human rabies vaccines"],"prefix":"10.1016","volume":"55","author":[{"given":"Zejun","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianfu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darin S.","family":"Carroll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenli","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaqi","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinrong","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxin","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gelin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengli","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.biologicals.2018.06.003_bib1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003502","article-title":"The spatiotemporal expansion of human rabies and its probable explanation in mainland China, 2004-2013","volume":"9","author":"Yao","year":"2015","journal-title":"PLoS Neglected Trop Dis"},{"issue":"1","key":"10.1016\/j.biologicals.2018.06.003_bib2","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.biologicals.2005.07.004","article-title":"A simple immuno-capture ELISA to estimate rabies viral glycoprotein antigen in vaccine manufacture","volume":"34","author":"Nagarajan","year":"2006","journal-title":"Biologicals"},{"issue":"4","key":"10.1016\/j.biologicals.2018.06.003_bib3","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0092-1157(89)80001-0","article-title":"Standardization of an enzyme immunoassay for the in vitro potency assay of inactivated tissue culture rabies vaccines: determination of the rabies virus glycoprotein with polyclonal antisera","volume":"17","author":"Thraenhart","year":"1989","journal-title":"J Biol Stand"},{"issue":"50","key":"10.1016\/j.biologicals.2018.06.003_bib4","doi-asserted-by":"crossref","first-page":"6022","DOI":"10.1016\/j.vaccine.2013.10.019","article-title":"A relevant in vitro ELISA test in alternative to the in vivo NIH test for human rabies vaccine batch release","volume":"31","author":"Gibert","year":"2013","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.biologicals.2018.06.003_bib5","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1128\/CVI.00204-10","article-title":"Recombinant diabody-based immunocapture enzyme-linked immunosorbent assay for quantification of rabies virus glycoprotein","volume":"17","author":"Nimmagadda","year":"2010","journal-title":"Clin Vaccine Immunol"},{"issue":"4","key":"10.1016\/j.biologicals.2018.06.003_bib6","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/1045-1056(90)90037-Z","article-title":"In vitro rabies vaccine potency appraisal by ELISA: advantages of the immunocapture method with a neutralizing anti-glycoprotein monoclonal antibody","volume":"18","author":"Perrin","year":"1990","journal-title":"Biologicals"},{"issue":"5","key":"10.1016\/j.biologicals.2018.06.003_bib7","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.biologicals.2012.07.005","article-title":"Report on the international workshop on alternative methods for human and veterinary rabies vaccine testing: state of the science and planning the way forward","volume":"40","author":"Stokes","year":"2012","journal-title":"Biologicals"},{"issue":"2","key":"10.1016\/j.biologicals.2018.06.003_bib8","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.vaccine.2013.11.026","article-title":"A novel site-II directed glycoprotein estimation ELISA to aid rabies vaccine manufacture for veterinary and human use","volume":"32","author":"Abhinay","year":"2014","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.biologicals.2018.06.003_bib9","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S1045-1056(02)00070-2","article-title":"Inactivated rabies vaccine control and release: use of an ELISA method","volume":"31","author":"Fournier-Caruana","year":"2003","journal-title":"Biologicals"},{"issue":"6","key":"10.1016\/j.biologicals.2018.06.003_bib10","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1292\/jvms.65.685","article-title":"Establishment of a potency test by ELISA for a rabies vaccine for animal use in Japan","volume":"65","author":"Gamoh","year":"2003","journal-title":"J Vet Med Sci"},{"issue":"6","key":"10.1016\/j.biologicals.2018.06.003_bib11","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.vaccine.2016.12.039","article-title":"Replacement of in vivo human rabies vaccine potency testing by in vitro glycoprotein quantification using ELISA - results of an international collaborative study","volume":"35","author":"Morgeaux","year":"2017","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.biologicals.2018.06.003_bib12","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0092-1157(81)80068-6","article-title":"The antibody-binding-test, a useful method for quantitative determination of inactivated rabies virus antigen","volume":"9","author":"Barth","year":"1981","journal-title":"J Biol Stand"},{"issue":"Pt 1","key":"10.1016\/j.biologicals.2018.06.003_bib13","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1099\/0022-1317-59-1-197","article-title":"A single-radial-immunodiffusion technique for the assay of rabies glycoprotein antigen: application for potency tests of vaccines against rabies","volume":"59","author":"Ferguson","year":"1982","journal-title":"J Gen Virol"},{"key":"10.1016\/j.biologicals.2018.06.003_bib14","first-page":"267","article-title":"Quantitative determination of rabies antigen by ELISA","volume":"50","author":"van der Marel","year":"1981","journal-title":"Dev Biol Stand"},{"issue":"4","key":"10.1016\/j.biologicals.2018.06.003_bib15","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0092-1157(85)80042-1","article-title":"Use of a monoclonal antibody for quantitation of rabies vaccine glycoprotein by enzyme immunoassay","volume":"13","author":"Lafon","year":"1985","journal-title":"J Biol Stand"},{"issue":"2","key":"10.1016\/j.biologicals.2018.06.003_bib16","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S1045-1056(05)80062-4","article-title":"Report of a collaborative study to assess the determination of glycoprotein antigen content of rabies vaccines for human use","volume":"20","author":"Ferguson","year":"1992","journal-title":"Biologicals"},{"issue":"2","key":"10.1016\/j.biologicals.2018.06.003_bib17","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1006\/biol.1996.0012","article-title":"Use of ELISA for in vitro potency test of rabies vaccines for animal use","volume":"24","author":"Gamoh","year":"1996","journal-title":"Biologicals"},{"issue":"1\u20132","key":"10.1016\/j.biologicals.2018.06.003_bib18","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0166-0934(95)01999-5","article-title":"Rabies vaccine potency control: comparison of ELISA systems for antigenicity testing","volume":"58","author":"Rooijakkers","year":"1996","journal-title":"J Virol Methods"},{"key":"10.1016\/j.biologicals.2018.06.003_bib19","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.biologicals.2017.02.002","article-title":"G-protein based ELISA as a potency test for rabies vaccines","volume":"46","author":"Chabaud-Riou","year":"2017","journal-title":"Biologicals"},{"issue":"6","key":"10.1016\/j.biologicals.2018.06.003_bib20","doi-asserted-by":"crossref","DOI":"10.1007\/s12250-009-3030-7","article-title":"A comparison of complete genome sequences of a rabies virus Chinese isolate SH06 with the vaccine strains","volume":"24","author":"Meng","year":"2009","journal-title":"Virol Sin"},{"issue":"4","key":"10.1016\/j.biologicals.2018.06.003_bib21","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.biologicals.2006.10.002","article-title":"A simple sandwich ELISA (WELYSSA) for the detection of lyssavirus nucleocapsid in rabies suspected specimens using mouse monoclonal antibodies","volume":"35","author":"Xu","year":"2007","journal-title":"Biologicals"},{"key":"10.1016\/j.biologicals.2018.06.003_bib22","first-page":"23","article-title":"Preparation and application of McABs to rabies virus glycoprotein and nucleoprotein","volume":"1","author":"Xu","year":"1996","journal-title":"Cninese J. Biol."},{"key":"10.1016\/j.biologicals.2018.06.003_bib23","first-page":"1754","article-title":"Establishment and validation of the rapid identification test on rabies vaccine by ELISA methods","volume":"9","author":"Shou-Chun","year":"2011","journal-title":"Chin J Pharm Anal"},{"issue":"6","key":"10.1016\/j.biologicals.2018.06.003_bib24","doi-asserted-by":"crossref","first-page":"946","DOI":"10.3201\/eid1506.081485","article-title":"Rabies in ferret badgers, southeastern China","volume":"15","author":"Zhang","year":"2009","journal-title":"Emerg Infect Dis"},{"issue":"8","key":"10.1016\/j.biologicals.2018.06.003_bib25","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.3201\/eid1508.081426","article-title":"Reemerging rabies and lack of systemic surveillance in People's Republic of China","volume":"15","author":"Wu","year":"2009","journal-title":"Emerg Infect Dis"}],"container-title":["Biologicals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105618302057?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105618302057?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,7]],"date-time":"2018-09-07T11:12:06Z","timestamp":1536318726000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1045105618302057"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":25,"alternative-id":["S1045105618302057"],"URL":"https:\/\/doi.org\/10.1016\/j.biologicals.2018.06.003","relation":{},"ISSN":["1045-1056"],"issn-type":[{"value":"1045-1056","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of a relative potency test using ELISA for human rabies vaccines","name":"articletitle","label":"Article Title"},{"value":"Biologicals","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biologicals.2018.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 International Alliance for Biological Standardization. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}